This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, Y.-W. Articles by Morita, I. Search for Related Content PubMed PubMed Citation Articles by Zhang, Y.-W. Articles by Morita, I.

A Novel Route for Connexin 43 to Inhibit Cell Proliferation: Negative Regulation of S-Phase Kinase-associated Protein (Skp 2)

Department of Cellular Physiological Chemistry, Tokyo Medical and Dental University, Tokyo 113-8549 [Y-W. Z., I. M.], and the Department of Molecular Genetics, Kyushu University, Fukuoka 812-8582 [K. N., K-I. N.], Japan

Accumulated evidence suggests that connexin43 (Cx43) serves as a tumor-suppressing gene. We have previously shownA. B. that Cx43 suppressed the G₁-S phase cell cycle transition via increasing the level of p27 (Zhang, Y. W., et al., Oncogene, 20: 4138–4149, 2001). Here we report that Cx43 inhibited expression of Skp2, the human F-box protein that regulates p27 ubiquitination. This reduction was attributed to an increased degradation of Skp2. The Cx43 antisense oligonucleotide blocked this inhibitory effect of Cx43 on Skp2 expression and led to p27 down-regulation. In contrast, the antisense oligonucleotide of Skp2 induced a further increase in the level of p27. However, ectopic expression of Skp2 reversed the Cx43-induced Skp2 reduction, p27 accumulation, and cell proliferation inhibition. Cx43 increased p27 expression only in the SKP2 +/+ mouse embryo fibroblasts (MEFs), but not in the SKP2 -/- MEFs, indicating that Skp2 plays a critical role in the Cx43-induced p27 up-regulation. We also show that both Skp2 and p27 are required for Cx43 to inhibit cell proliferation, in that Cx43 hardly inhibited cell proliferation of the SKP2 -/- and p27 -/- MEFs, whereas it clearly did both in the SKP2 +/- and in the p27 +/- MEFs. Our findings suggest a new route for Cx43 to inhibit tumor growth by linking it with the key cell cycle regulators.

This article has been cited by other articles:

				S. Sridharan, L. Simon, D. D. Meling, D. G. Cyr, D. E. Gutstein, G. I. Fishman, F. Guillou, and P. S. Cooke Proliferation of Adult Sertoli Cells Following Conditional Knockout of the Gap Junctional Protein GJA1 (Connexin 43) in Mice Biol Reprod, May 1, 2007; 76(5): 804 - 812. [Abstract] [Full Text] [PDF]

				J. Kalra, Q. Shao, H. Qin, T. Thomas, M. A. Alaoui-Jamali, and D. W. Laird Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism Carcinogenesis, December 1, 2006; 27(12): 2528 - 2537. [Abstract] [Full Text] [PDF]

				C. E. Chadjichristos, C. M. Matter, I. Roth, E. Sutter, G. Pelli, T. F. Luscher, M. Chanson, and B. R. Kwak Reduced Connexin43 Expression Limits Neointima Formation After Balloon Distension Injury in Hypercholesterolemic Mice Circulation, June 20, 2006; 113(24): 2835 - 2843. [Abstract] [Full Text] [PDF]

				Q. Shao, H. Wang, E. McLachlan, G. I.L. Veitch, and D. W. Laird Down-regulation of Cx43 by Retroviral Delivery of Small Interfering RNA Promotes an Aggressive Breast Cancer Cell Phenotype Cancer Res., April 1, 2005; 65(7): 2705 - 2711. [Abstract] [Full Text] [PDF]

				A. Gellhaus, X. Dong, S. Propson, K. Maass, L. Klein-Hitpass, M. Kibschull, O. Traub, K. Willecke, B. Perbal, S. J. Lye, et al. Connexin43 Interacts with NOV: A POSSIBLE MECHANISM FOR NEGATIVE REGULATION OF CELL GROWTH IN CHORIOCARCINOMA CELLS J. Biol. Chem., August 27, 2004; 279(35): 36931 - 36942. [Abstract] [Full Text] [PDF]

				C. T. Fu, J. F. Bechberger, M. A. Ozog, B. Perbal, and C. C. Naus CCN3 (NOV) Interacts with Connexin43 in C6 Glioma Cells: POSSIBLE MECHANISM OF CONNEXIN-MEDIATED GROWTH SUPPRESSION J. Biol. Chem., August 27, 2004; 279(35): 36943 - 36950. [Abstract] [Full Text] [PDF]

				A. Ougolkov, B. Zhang, K. Yamashita, V. Bilim, M. Mai, S. Y. Fuchs, and T. Minamoto Associations Among {beta}-TrCP, an E3 Ubiquitin Ligase Receptor, {beta}-Catenin, and NF-{kappa}B in Colorectal Cancer J Natl Cancer Inst, August 4, 2004; 96(15): 1161 - 1170. [Abstract] [Full Text] [PDF]

				T. J. King and P. D. Lampe Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation Carcinogenesis, May 1, 2004; 25(5): 669 - 680. [Abstract] [Full Text] [PDF]

				Y.-W. Zhang, M. Kaneda, and I. Morita The Gap Junction-independent Tumor-suppressing Effect of Connexin 43 J. Biol. Chem., November 7, 2003; 278(45): 44852 - 44856. [Abstract] [Full Text] [PDF]

				D. R. Holsberger, S. Jirawatnotai, H. Kiyokawa, and P. S. Cooke Thyroid Hormone Regulates the Cell Cycle Inhibitor p27Kip1 in Postnatal Murine Sertoli Cells Endocrinology, September 1, 2003; 144(9): 3732 - 3738. [Abstract] [Full Text] [PDF]

				G. Olbina and W. Eckhart Mutations in the Second Extracellular Region of Connexin 43 Prevent Localization to the Plasma Membrane, but Do Not Affect Its Ability to Suppress Cell Growth Mol. Cancer Res., July 1, 2003; 1(9): 690 - 700. [Abstract] [Full Text] [PDF]